Gregory H. Reaman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Gregory H. Reaman has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- CP REYNOLDS
Pediatric Cancer Research Center and Department of Pediatrics, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
2 shared publications - Fatih Ozsolak
Helicos BioSciences Corporation, One Kendall Square, Building 700, Cambridge, MA 02139, USA
2 shared publications - Georges St Laurent
St. Laurent Institute Cambridge, MA, USA
2 shared publications - John F. Thompson
PGDx
2 shared publications - Patrice M. Milos
Helicos BioSciences Corporation, One Kendall Square, Building 700, Cambridge, MA 02139, USA
2 shared publications - Philipp Kapranov
St. Laurent Institute Cambridge, MA, USA
2 shared publications
Latest Publications
- Open Access
- 20 December 2011
- Published by Springer Nature in BMC Biology
- Vol. 9 (1) , 86
Erratum to: The majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNA
- 20 December 2011
- Published by Springer Nature in BMC Biology
- Vol. 9 (1) , 86
Open AccessErratum to: The majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNA
- Open Access
- 21 December 2010
- Published by Springer Nature in BMC Biology
- Vol. 8 (1) , 1-15
The majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNA
Discovery that the transcriptional output of the human genome is far more complex than predicted by the current set of protein-coding annotations and that most RNAs produced do not appear to encode proteins has transformed our understanding of genome complexity and suggests new paradigms of genome regulation. However, the fraction of all cellular RNA whose function we do not understand and the fraction of the genome that is utilized to produce that RNA remain controversial. This is not simply a bookkeeping issue because the degree to which this un-annotated transcription is present has important implications with respect to its biologic function and to the general architecture of genome regulation. For example, efforts to elucidate how non-coding RNAs (ncRNAs) regulate genome function will be compromised if that class of RNAs is dismissed as simply 'transcriptional noise'. We show that the relative mass of RNA whose function and/or structure we do not understand (the so called 'dark matter' RNAs), as a proportion of all non-ribosomal, non-mitochondrial human RNA (mt-RNA), can be greater than that of protein-encoding transcripts. This observation is obscured in studies that focus only on polyA-selected RNA, a method that enriches for protein coding RNAs and at the same time discards the vast majority of RNA prior to analysis. We further show the presence of a large number of very long, abundantly-transcribed regions (100's of kb) in intergenic space and further show that expression of these regions is associated with neoplastic transformation. These overlap some regions found previously in normal human embryonic tissues and raises an interesting hypothesis as to the function of these ncRNAs in both early development and neoplastic transformation. We conclude that 'dark matter' RNA can constitute the majority of non-ribosomal, non-mitochondrial-RNA and a significant fraction arises from numerous very long, intergenic transcribed regions that could be involved in neoplastic transformation.
- 21 December 2010
- Published by Springer Nature in BMC Biology
- Vol. 8 (1) , 1-15
Open AccessThe majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNA
Discovery that the transcriptional output of the human genome is far more complex than predicted by the current set of protein-coding annotations and that most RNAs produced do not appear to encode proteins has transformed our understanding of genome complexity and suggests new paradigms of genome regulation. However, the fraction of all cellular RNA whose function we do not understand and the fraction of the genome that is utilized to produce that RNA remain controversial. This is not simply a bookkeeping issue because the degree to which this un-annotated transcription is present has important implications with respect to its biologic function and to the general architecture of genome regulation. For example, efforts to elucidate how non-coding RNAs (ncRNAs) regulate genome function will be compromised if that class of RNAs is dismissed as simply 'transcriptional noise'. We show that the relative mass of RNA whose function and/or structure we do not understand (the so called 'dark matter' RNAs), as a proportion of all non-ribosomal, non-mitochondrial human RNA (mt-RNA), can be greater than that of protein-encoding transcripts. This observation is obscured in studies that focus only on polyA-selected RNA, a method that enriches for protein coding RNAs and at the same time discards the vast majority of RNA prior to analysis. We further show the presence of a large number of very long, abundantly-transcribed regions (100's of kb) in intergenic space and further show that expression of these regions is associated with neoplastic transformation. These overlap some regions found previously in normal human embryonic tissues and raises an interesting hypothesis as to the function of these ncRNAs in both early development and neoplastic transformation. We conclude that 'dark matter' RNA can constitute the majority of non-ribosomal, non-mitochondrial-RNA and a significant fraction arises from numerous very long, intergenic transcribed regions that could be involved in neoplastic transformation.
- 5 October 2010
- Published by Springer Nature
- p. 193-214
Promising Targeted Agents
- 5 October 2010
- Published by Springer Nature
- p. 325-330
Future Challenges and Opportunities to Improve Outcomes for Children with Leukemia
- 5 October 2010
- Published by Springer Nature
- p. 325-330
Future Challenges and Opportunities to Improve Outcomes for Children with Leukemia
- 5 October 2010
- Published by Springer Nature
- p. 305-322
Improved Outcome for Children with Acute Leukemia: How to Address Global Disparities
- 5 October 2010
- Published by Springer Nature
- p. 305-322
Improved Outcome for Children with Acute Leukemia: How to Address Global Disparities
- 16 December 2008
- Published by Springer Nature in Pediatric Radiology
- Vol. 39 (1) , 42-45
What, why, and when we image: considerations for diagnostic imaging and clinical research in the Children’s Oncology Group
- 16 December 2008
- Published by Springer Nature in Pediatric Radiology
- Vol. 39 (1) , 42-45
What, why, and when we image: considerations for diagnostic imaging and clinical research in the Children’s Oncology Group
- 1 December 2002
- Published by Elsevier in Pediatric Clinics of North America
- Vol. 49 (6) , 1305-1318
Pediatric oncology: current views and outcomes
- 1 December 2002
- Published by Elsevier in Pediatric Clinics of North America
- Vol. 49 (6) , 1305-1318
Pediatric oncology: current views and outcomes